Global Drug Repurposing Market: Overview
National Institute of Health (NIH), of the US Department of Health offers the drug repurposing and gaining new approvals along with widening usage of the drug repurposing. It has numerous potential opportunities for growth by catering the unmet medical needs with some cost-effective solutions as alternative to the expensive drugs.
The global drug repurposing market report from Transparency market research offers the insights on the market dynamics. The report briefs the factors such as drivers, opportunities, trends, and restrains. The drug repurposing market report represents extensive outlook of the key players such as Porter’s five forces and SWOT analysis. Also, it provides the information such as merger and acquisition (M&A), research & development (R&D), and investment and profit analysis of the key players dominating the drug repurposing market.
Global Drug Repurposing Market: Drivers and Restraints
Need of the low investment in terms of time and money is fuelling demand for the drug repurposing which is leading to increase number of pipeline products is propelling growth of the drug repurposing market. Additionally, some of the other factors propelling growth of the global drug repurposing market are low research cost and easy bioavailability is propelling its growth from past few years. Additionally, it is a bio-based products which lowers the possibility of side effects and enhances the potential to reposition. This factor is propelling growth of the global drug repurposing market. However, lack of funding and limited information is restraining growth of the global drug repurposing market.
Global Drug Repurposing Market: Geographical Analysis
Based on geography, the market has been segmented into the following regions: North America, Europe, Latin America, Asia Pacific, Latin America and the Middle East and Africa. Of these, North America is expected to dominate the drug repurposing market. This growth is attributable to the high rates of expenses on research and treatments.
Global Drug Repurposing Market: Companies Mentioned
Some of the key players operating in the global drug repurposing market are Astellas Pharma, Biovista, Novartis, AbbVie, Pfizer, Allergan, and NuMedii.
Market segmentation based on geography:
- North America
- South America
- Asia Pacific
- Middle East and Africa
This report gives access to decisive data, such as:
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for the coming years
Key highlights of this report include:
- Overview of key market forces propelling and restraining market growth
- Up-to-date analyses of market trends and technological improvements
- Pin-point analyses of market competition dynamics to offer you a competitive edge
- An analysis of strategies of major competitors
- An array of graphics and SWOT analysis of major industry segments
- Detailed analyses of industry trends
- A well-defined technological growth map with an impact-analysis
- Offers a clear understanding of the competitive landscape and key product segments
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.